Date of prep: December 2020
Prescribing information and
adverse events reporting
For healthcare professionals only
Kent Pharmaceuticals Ltd has informed the MHRA that several batches of the finished product were contaminated with theophylline due to a cross-contamination issue identified with an excipient that was used in the manufacture of the finished product.
This circular is being shared under the Open Government Copyright licence.
Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.